HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ruth A Karron Selected Research

Respiratory Syncytial Virus Vaccines

1/2020Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting.
12/2018Informing randomized clinical trials of respiratory syncytial virus vaccination during pregnancy to prevent recurrent childhood wheezing: A sample size analysis.
10/2018The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates.
10/2007The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines.
12/2004Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ruth A Karron Research Topics

Disease

10Pneumonia (Pneumonitis)
11/2020 - 01/2007
10Paramyxoviridae Infections (Parainfluenza)
12/2015 - 05/2003
8Human Influenza (Influenza)
10/2017 - 11/2010
7Infections
01/2022 - 05/2002
6Respiratory Syncytial Virus Infections
01/2021 - 12/2004
6Respiratory Sounds (Crackle)
11/2020 - 06/2004
3Fever (Fevers)
11/2018 - 06/2013
3Respiratory Tract Infections (Respiratory Tract Infection)
02/2016 - 08/2002
2COVID-19
01/2022 - 01/2022
2Malaria
01/2019 - 02/2016
2Hypergammaglobulinemia (Hyperimmunoglobulinemia)
01/2019 - 02/2016
1Emerging Communicable Diseases (Emerging Infectious Diseases)
01/2021
1Asthma (Bronchial Asthma)
01/2020
1Premature Birth (Birth, Premature)
01/2019
1HIV Infections (HIV Infection)
01/2019
1Communicable Diseases (Infectious Diseases)
10/2018
1Bacterial Pneumonia
06/2017
1Pneumococcal Pneumonia
06/2017
1Pregnancy Complications
01/2017
1Tachypnea
12/2016
1Tachycardia (Tachyarrhythmias)
12/2016
1Hypersensitivity (Allergy)
12/2015
1Influenza in Birds (Avian Flu)
06/2009
1Pulmonary Eosinophilia (Eosinophilic Pneumonia)
01/2007
1Eosinophilia
01/2007
1Inflammation (Inflammations)
06/2005
1Cough
06/2004
1Rhinorrhea
06/2004

Drug/Important Bio-Agent (IBA)

25VaccinesIBA
01/2021 - 05/2003
5Respiratory Syncytial Virus VaccinesIBA
01/2020 - 12/2004
4Influenza Vaccines (Influenza Vaccine)FDA Link
10/2017 - 06/2009
4Anti-Bacterial Agents (Antibiotics)IBA
06/2017 - 04/2012
3Neutralizing AntibodiesIBA
01/2022 - 10/2008
2Monoclonal AntibodiesIBA
01/2020 - 12/2015
2Immunoglobulin G (IgG)IBA
01/2019 - 10/2008
2C-Reactive ProteinIBA
06/2017 - 06/2017
2motavizumab (Numax)IBA
12/2016 - 12/2015
2Glycoproteins (Glycoprotein)IBA
10/2008 - 06/2005
2GTP-Binding Proteins (G-Protein)IBA
12/2004 - 05/2002
1Pharmaceutical PreparationsIBA
01/2022
1Coloring Agents (Dyes)IBA
06/2017
1N-Acetylmuramoyl-L-alanine Amidase (Autolysin)IBA
06/2017
1DNA (Deoxyribonucleic Acid)IBA
06/2017
1Biological ProductsIBA
01/2017
1ORALIT (ORS)IBA
12/2016
1Immunoglobulins (Immunoglobulin)IBA
02/2016
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
01/2013
1Complement System Proteins (Complement)IBA
01/2007
1Antigen-Antibody Complex (Immune Complex)IBA
01/2007
1CytokinesIBA
06/2004
1Attenuated VaccinesIBA
02/2004
1EnzymesIBA
08/2002
1Amino AcidsFDA Link
05/2002
1AntibodiesIBA
05/2002
1AA 193IBA
05/2002

Therapy/Procedure

1Stethoscopes
11/2020
1Contraindications
08/2016
1Therapeutics
04/2012